Study Information

Title: A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver External
Status: Recruiting participants
Conditions: Hepatocellular Carcinoma
Interventions: Biological: IMC-A12 (cixutumumab); Biological: IMC-A12 (cixutumumab); Drug: sorafenib
Health Topics: Liver Cancer

Contact Information


ImClone Investigational Site
Burlington, MA 01805